PMID: 21429822

Coiana A, Faa' V, Carta D, Puddu R, Cao A, Rosatelli MC
Preconceptional identification of cystic fibrosis carriers in the Sardinian population: A pilot screening program.
J Cyst Fibros. 2011 May;10(3):207-11. doi: 10.1016/j.jcf.2011.02.006. Epub 2011 Mar 22., [PubMed]
Sentences
No. Mutations Sentence Comment
6 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:6:36
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:6:47
status: NEW
view ABCC7 p.Thr338Ile details
The most common CF allele was the p.Thr338Ile (T338I) (65%), followed by the p.Phe508del (F508del) (22.5%). Login to comment
7 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:7:86
status: NEW
view ABCC7 p.Thr338Ile details
We also identified one couple at risk and an asymptomatic female homozygote for the p.Thr338Ile allele. Login to comment
80 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:80:36
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:80:47
status: NEW
view ABCC7 p.Thr338Ile details
The most common CF allele was the p.Thr338Ile (T338I) (65%), followed by the p.Phe508del (F508del) (22.5%). Login to comment
81 ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 21429822:81:92
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 21429822:81:6
status: NEW
view ABCC7 p.Asn1303Lys details
The p.Asn1303Lys, c.2051_2052delAAinsG, c.489+ 1GNT, c.54-5811_164+2187del8108ins182, and p.Arg347Pro mutations were found once, with a frequency of 2.5% each. Login to comment
82 ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 21429822:82:6
status: NEW
view ABCC7 p.Arg347Pro details
The p.Arg347Pro mutation, never detected in Sardinian patients until now, was reported to have an overall frequency of 0.8% in the Italian population (WHO, [18]). Login to comment
88 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 21429822:88:558
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 21429822:88:567
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21429822:88:724
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21429822:88:733
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 21429822:88:357
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21429822:88:520
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 21429822:88:378
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 21429822:88:388
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 21429822:88:249
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 21429822:88:258
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 21429822:88:96
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 21429822:88:106
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21429822:88:476
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 21429822:88:867
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 21429822:88:579
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 21429822:88:594
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 21429822:88:313
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 21429822:88:321
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:88:35
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:88:44
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 21429822:88:768
status: NEW
view ABCC7 p.Leu1065Pro details
ABCC7 p.Leu1065Pro
X
ABCC7 p.Leu1065Pro 21429822:88:778
status: NEW
view ABCC7 p.Leu1065Pro details
ABCC7 p.Arg1158*
X
ABCC7 p.Arg1158* 21429822:88:888
status: NEW
view ABCC7 p.Arg1158* details
ABCC7 p.Gln552*
X
ABCC7 p.Gln552* 21429822:88:539
status: NEW
view ABCC7 p.Gln552* details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 21429822:88:745
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 21429822:88:755
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 21429822:88:629
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 21429822:88:638
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 21429822:88:814
status: NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Leu1077Pro
X
ABCC7 p.Leu1077Pro 21429822:88:824
status: NEW
view ABCC7 p.Leu1077Pro details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 21429822:88:791
status: NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 21429822:88:801
status: NEW
view ABCC7 p.Arg1066His details
ABCC7 p.Ile502Thr
X
ABCC7 p.Ile502Thr 21429822:88:650
status: NEW
view ABCC7 p.Ile502Thr details
ABCC7 p.Ile502Thr
X
ABCC7 p.Ile502Thr 21429822:88:659
status: NEW
view ABCC7 p.Ile502Thr details
ABCC7 p.Ser912*
X
ABCC7 p.Ser912* 21429822:88:967
status: NEW
view ABCC7 p.Ser912* details
ABCC7 p.Ser912*
X
ABCC7 p.Ser912* 21429822:88:969
status: NEW
view ABCC7 p.Ser912* details
Mutation nomenclaturea Alleles (%) T338I (p.Thr338Ile) 26 (65.0) F508del (p.Phe508del) 9 (22.5) N1303K (p.Asn1303Lys) 1 (2.5) 2183AANG (c.2051_2052delAAinsG) 1 (2.5) 621+1GNT (c.489+1GNT) 1 (2.5) exon 2 del (c.54-5811_164+2187del8108ins182) 1 (2.5) R347P (p.Arg347Pro) 1 (2.5) The 3849+10kbCNT (c.3717+12191CNT), G85E (p.Gly85Glu), 2789+5GNA (c.2657+5GNA), W1282X (p.Trp1282X), G1244E (p.Gly1244Glu), 711+5GNA (c.579+5GNA), 711+1GNT (c.579+1GNA), 4016insT (p.Ser1297PhefsX5), G542X (p.Gly542X), 1717-1GNA (c.1585-1GNA), R553X (p.Arg553X), Q552X (p.Gln552X), G551D (p.Gly551Asp), S549R (ANC) (p.Ser549Arg), I507del (p.Ile507del), F508C (p.Phe508Cys), I502T (p.Ile502Thr), 1706del17 (p.Gln525LeufsX37), 1677delTA (p.Tyr515X), R117H (p.Arg117His), D1152H (p.Asp1152His), L1065P (p.Leu1065Pro), R1066H (p.Arg1066His), L1077P (p.Leu1077Pro), 4382delA (p.Glu1418ArgfsX14), R1162X (p.Arg1162X), R1158X (p.Arg1158X), 1259 insA (p.Gln378AlafsX4), 852del22 (p.Gly241GlufsX13), S912X (p.Ser912X), and 991del5bp (p.Asn287LysfsX19) mutations included in the CF panel were not detected in the population tested. Login to comment
92 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:92:57
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:92:68
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:92:132
status: NEW
view ABCC7 p.Thr338Ile details
An asymptomatic 43 year old female homozygous for the p. Thr338Ile (T338I) allele was also identified (Table 3) whose parents, both T338I heterozygotes, were first cousins. Login to comment
121 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:121:70
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:121:81
status: NEW
view ABCC7 p.Thr338Ile details
Our study showed that the most frequent mutation in Sardinia is the p.Thr338Ile (T338I) (65%), a mild mutation previously described by our group in Sardinian CF patients either in homozygous state (11 patients) or in compound heterozygous state with other severe mutations (18 patients) [16,17]. Login to comment
124 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:124:28
status: NEW
view ABCC7 p.Thr338Ile details
Patients homozygous for the T338I mutation are often asymptomatic otherwise showing a very mild phenotype. Login to comment
125 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:125:61
status: NEW
view ABCC7 p.Thr338Ile details
Clinical manifestation of patient compound heterozygotes for T338I and other severe mutation are slightly more severe ranging from isolated azoospermia, with or without CBAVD, to mild CF phenotype characterized by a mild to moderate pulmonary involvement. Login to comment
127 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:127:63
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:127:69
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:127:87
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:127:112
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:127:139
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Arg1066His
X
ABCC7 p.Arg1066His 21429822:127:145
status: NEW
view ABCC7 p.Arg1066His details
Moreover seven patients belonging from both groups (3 patients T338I/T338I, 2 patients T338I/F508del, 1 patient T338I/ 2183AANG, 1 patient T338I/R1066H), affected by azoospermia with no other CF symptoms, were occasionally identified when they requested CF genetic test for assisted reproduction technologies (ART) (Rosatelli, personal communication). Login to comment
128 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:128:77
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:128:88
status: NEW
view ABCC7 p.Thr338Ile details
There is statistically significant difference between the frequency of the p.Thr338Ile (T338I) allele (65%), highlighted in the present study, and the findings of our previous study on Sardinian CF patients (19.3%) (p=0.0001) [12]. Login to comment
132 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:132:14
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:132:25
status: NEW
view ABCC7 p.Thr338Ile details
c Genotype: p.Thr338Ile (T338I) homozygote. Login to comment
134 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:134:84
status: NEW
view ABCC7 p.Thr338Ile details
ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:134:95
status: NEW
view ABCC7 p.Thr338Ile details
As alluded above, this discrepancy is likely due to the mild phenotype of patient p.Thr338Ile (T338I) homozygotes or compound heterozygotes which can escape a diagnosis. Login to comment
136 ABCC7 p.Thr338Ile
X
ABCC7 p.Thr338Ile 21429822:136:143
status: NEW
view ABCC7 p.Thr338Ile details
In the counseling session, patients as well as couples at risk should be exhaustively informed about the asymptomatic or mild phenotype of the T338I allele. Login to comment